Mutual funds add defensives IT & pharma as Omicron, valuations weigh

Invesco India bought into Vodafone Idea as the company could be a benefi ciary post the 25% tariff hike, Mirae bought into Bayer CropScience and DSP bought into Thangamayil Jewellery ahead of the wedding season.

Getty Images
They also picked specific mid- and small-cap stocks with earnings visibility. Among pharma stocks, fund managers found comfort in Laurus Labs and Alembic Pharma.
Amid steep valuations, uncertainty over the omicron variant, and subsequent lockdowns, and a 6% correction in the Nifty in November, fund managers bought into defensive sectors like IT and Pharma.

They also picked specific mid- and small-cap stocks with earnings visibility. Among pharma stocks, fund managers found comfort in Laurus Labs and Alembic Pharma.

In midcap IT, they preferred Zensar Tech and Firstsource Solutions. Invesco India bought into Vodafone Idea as the company could be a benefi ciary post the 25% tariff hike, Mirae bought into Bayer CropScience and DSP bought into Thangamayil Jewellery ahead of the wedding season.


ET takes a look at some of mutual funds’ prominent purchases and sales

MF

Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

Top Mutual Funds

3 M(%)
6 M(%)
1 YR(%)
3 YRS(%)

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Save with Tax planning SIP's

More from our Partners

Loading next story
Business News › Mutual Funds › Analysis › Mutual funds add defensives IT & pharma as Omicron, valuations weigh
Text Size:AAA
Success
This article has been saved

*

+